Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Bone marrow-liver-thymus (BLT) immune humanized mice as a model to predict cytokine release syndrome.

Yan H, Semple KM, Gonzaléz CM, Howard KE.

Transl Res. 2019 Aug;210:43-56. doi: 10.1016/j.trsl.2019.04.007. Epub 2019 Apr 22.

PMID:
31082370
2.

Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models.

Yan H, Bhagwat B, Sanden D, Willingham A, Tan A, Knapton AD, Weaver JL, Howard KE.

Toxicol Appl Pharmacol. 2019 Jun 1;372:57-69. doi: 10.1016/j.taap.2019.03.020. Epub 2019 Mar 23.

PMID:
30914376
3.

BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains.

Weaver JL, Zadrozny LM, Gabrielson K, Semple KM, Shea KI, Howard KE.

Toxicol Sci. 2019 May 1;169(1):194-208. doi: 10.1093/toxsci/kfz045.

PMID:
30850839
4.

Evaluation of the Ability of Immune Humanized Mice to Demonstrate CD20-Specific Cytotoxicity Induced by Ofatumumab.

Semple KM, Gonzaléz CM, Zarr M, Austin JR, Patel V, Howard KE.

Clin Transl Sci. 2019 May;12(3):283-290. doi: 10.1111/cts.12613. Epub 2019 Feb 27.

5.
6.

Evaluating the potential of gold, silver, and silica nanoparticles to saturate mononuclear phagocytic system tissues under repeat dosing conditions.

Weaver JL, Tobin GA, Ingle T, Bancos S, Stevens D, Rouse R, Howard KE, Goodwin D, Knapton A, Li X, Shea K, Stewart S, Xu L, Goering PL, Zhang Q, Howard PC, Collins J, Khan S, Sung K, Tyner KM.

Part Fibre Toxicol. 2017 Jul 17;14(1):25. doi: 10.1186/s12989-017-0206-4.

7.

Nonclinical evaluation of the potential for mast cell activation by an erythropoietin analog.

Weaver JL, Boyne M, Pang E, Chimalakonda K, Howard KE.

Toxicol Appl Pharmacol. 2015 Sep 15;287(3):246-52. doi: 10.1016/j.taap.2015.06.009. Epub 2015 Jun 14.

PMID:
26079829
8.

Development and validation of a liquid-chromatography tandem mass spectrometry method to determine in vitro and in vivo histamine release.

Chimalakonda KC, Pang E, Weaver JL, Howard KE, Patel V, Boyne MT 2nd.

J Pharm Biomed Anal. 2015 Jan;102:494-9. doi: 10.1016/j.jpba.2014.10.016. Epub 2014 Oct 23.

PMID:
25459949
9.

In vivo assessment of natural killer cell responses during chronic feline immunodeficiency virus infection.

Simões RD, Howard KE, Dean GA.

PLoS One. 2012;7(5):e37606. doi: 10.1371/journal.pone.0037606. Epub 2012 May 31.

10.

Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.

Howard KE, Reckling SK, Egan EA, Dean GA.

Retrovirology. 2010 Jan 19;7:2. doi: 10.1186/1742-4690-7-2.

11.

An evaluation of the PALS after treatment modelling intervention to reduce dental anxiety in child dental patients.

Howard KE, Freeman R.

Int J Paediatr Dent. 2009 Jul;19(4):233-42. doi: 10.1111/j.1365-263X.2009.00977.x. Epub 2009 Mar 30.

PMID:
19486375
12.

Birth prevalence of cleft lip and palate in Northern Ireland (1981 to 2000).

Gregg TA, Leonard AG, Hayden C, Howard KE, Coyle CF.

Cleft Palate Craniofac J. 2008 Mar;45(2):141-7. doi: 10.1597/06-045.1.

PMID:
18333643
13.
15.

Reliability and validity of a faces version of the Modified Child Dental Anxiety Scale.

Howard KE, Freeman R.

Int J Paediatr Dent. 2007 Jul;17(4):281-8.

PMID:
17559456
16.
17.

Child coping strategies, dental anxiety and dental treatment: the influence of age, gender and childhood caries prevalence.

Van Meurs P, Howard KE, Versloot J, Veerkamp JS, Freeman R.

Eur J Paediatr Dent. 2005 Dec;6(4):173-8.

PMID:
16426115
18.

Methodology for isolation and phenotypic characterization of feline small intestinal leukocytes.

Howard KE, Fisher IL, Dean GA, Jo Burkhard M.

J Immunol Methods. 2005 Jul;302(1-2):36-53.

PMID:
16023664
19.

Toll-like receptor expression in feline lymphoid tissues.

Ignacio G, Nordone S, Howard KE, Dean GA.

Vet Immunol Immunopathol. 2005 Jul 15;106(3-4):229-37.

PMID:
15963821
20.
21.

Transforming growth factor-beta response to mycobacterial infection in striped bass Morone saxatilis and hybrid tilapia Oreochromis spp.

Harms CA, Howard KE, Wolf JC, Smith SA, Kennedy-Stoskopf S.

Vet Immunol Immunopathol. 2003 Oct 15;95(3-4):155-63.

PMID:
12963276

Supplemental Content

Loading ...
Support Center